ClinicalTrials.gg
Sign In

Cardio-Renal Syndrome clinical trials

The registry lists 85 studies for Cardio-Renal Syndrome across more than 10 countries. 20 are recruiting or about to start. 51 of them are mainly about Cardio-Renal Syndrome (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-05.

Get an email when these change. Save the Cardio-Renal Syndrome studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
33
Status unknown
14
Recruiting
12
Terminated
11
Not yet recruiting
7
Withdrawn
4

Phase

Phase 4
10
Phase 2
10
Phase 3
8
Phase 1
4

Where

United States
18
China
7
Germany
7
France
7
Mexico
4
Canada
3

Who runs them

Hospices Civils de Lyon (4) · Chinese PLA General Hospital (3) · Triomed AB (2) · Procyrion (2) · University of Giessen (2) · Hospital Civil de Guadalajara (2) · Odense University Hospital (2) · Haiyan Pan (2)

What is being tested here

Drugs under test in Cardio-Renal Syndrome studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Dapagliflozin113
Finerenone101
Empagliflozin111
Furosemide003
Dobutamine013
Spironolactone003
Simendan012
Milrinone002
Nesiritide002
Candesartan001

Drug classes tested here SGLT2 inhibitors 2 open · Mineralocorticoid receptor antagonists (MRAs) 1 open · Diuretics 6

Coming up

3phase 3 studies under way
6studies finish main data collection within a year2 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 6, phase 3 first

Who these studies take

Of the 12 Cardio-Renal Syndrome studies recruiting now, 9 (75%) set no upper age limit and 2 (17%) stop at 75 or younger. 2 (17%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 0 (0%) take healthy volunteers.

Recruiting studies that take each age, of 12
AgeWomenMen
101 (8%)1 (8%)
1811 (92%)11 (92%)
3012 (100%)12 (100%)
4012 (100%)12 (100%)
5012 (100%)12 (100%)
6512 (100%)12 (100%)
7512 (100%)12 (100%)
8510 (83%)10 (83%)

Across all 85 studies, recruiting or not: 11% stop at 75 or younger and 4% at 65; 6% take children; 0% are for women only and 2% for men only; 4% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

What changed recently

From the registry's own updates since Oct 15, 2026.

Started recruiting1

Newly registered1

Studies

Recruiting first, then most recently updated. Showing 50 of 85. Browse all 85 → or search them.